FDA Withdraws Approval of 18 Abbreviated New Drug Applications from Oxford Pharmaceuticals, LLC and Others

Summary

The US Food and Drug Administration (FDA) has withdrawn the approval of 18 abbreviated new drug applications (ANDAs) from multiple pharmaceutical companies, including Oxford Pharmaceuticals, LLC, after they notified the agency that the corresponding drug products are no longer commercially available.